Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
60.7M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
43.2M
-
Shares change
-
+17.2M
-
Total reported value, excl. options
-
$179M
-
Value change
-
+$71.1M
-
Put/Call ratio
-
1.12
-
Number of buys
-
46
-
Number of sells
-
-19
-
Price
-
$4.15
Significant Holders of Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) as of Q3 2023
85 filings reported holding ABOS - Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share as of Q3 2023.
Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.2M shares
of 60.7M outstanding shares and own 71.17% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (14.9M shares), Sands Capital Ventures, LLC (3.42M shares), FRANKLIN RESOURCES INC (2.84M shares), Rock Springs Capital Management LP (2.81M shares), Deep Track Capital, LP (2.51M shares), Boxer Capital, LLC (2.21M shares), Laurion Capital Management LP (1.9M shares), VANGUARD GROUP INC (1.86M shares), MILLENNIUM MANAGEMENT LLC (1.72M shares), and Knollwood Investment Advisory, LLC (1.63M shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.